483
Kamada, Ltd.Kamada, Ltd. – FDA 483, Feb 3, 2010
Record Details
An FDA Pre-License Inspection of Kamada, Ltd. in Negev, Israel, for their Alpha-1-Proteinase Inhibitor product, identified 13 significant observations. The findings highlight critical deficiencies in aseptic processing, sterilization validation, environmental monitoring, and quality control documentation. These issues indicate a need for improved controls to ensure product sterility and overall quality.
View Company Profile
ID · ecfd3473-4dd1-4176-9cfc-b5e7a0d02ba3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.